Nov 05, 2019 - Incyte (INCY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Oct 29, 2019 - Incyte Corporation's (NASDAQ:INCY) Q3 2019 Results Earnings Conference Call October 29, 2019, 08:00 AM ET Company Participants Michael Booth - Divisional Vice President of Investor Relations and Corpo
Oct 29, 2019 - INCY earnings call for the period ending September 30, 2019.
Oct 29, 2019 - Incyte (INCY) reports better-than-expected results for the third quarter of 2019, owing to strong Jakafi sales.
Oct 28, 2019 - Four drug/biotech stocks are scheduled to release third-quarter results on Oct 29. Let's see how these companies are placed before their earnings call.
Oct 28, 2019 - Sanofi's (SNY) Specialty Care and Vaccines units are likely to have driven third- quarter earnings.
Oct 25, 2019 - AbbVie's (ABBV) Q3 sales may have been weighed down by biosimilar competition for Humira in international markets. However, strong growth of oncology drugs might have offset impact of Humira's international sales erosion.
Oct 25, 2019 - During ACADIA's (ACAD) third-quarter 2019 conference call, investor focus will be on the sales figure of its only marketed drug Nuplazid and its label expansion studies.
Oct 25, 2019 - During Vertex's (VRTX) third-quarter earnings call, investor focus will be on the uptake of its newest CF drug Symdeko and the update on the recent approval of Trikafta triple combination regimen.
Oct 24, 2019 - BioMarin (BMRN) rides high on earnings and revenue beat in the third quarter of 2019.